GEM
Global Endowment Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,780
| Closed | -$577K | – | 120 |
|
|
2021
Q4 | $577K | Buy |
3,780
+1,380
| +58% | +$211K | 0.04% | 100 |
|
|
2021
Q3 | $388K | Hold |
2,400
| – | – | 0.03% | 101 |
|
|
2021
Q2 | $393K | Buy |
+2,400
| New | +$393K | 0.02% | 105 |
|
|
2020
Q4 | – | Sell |
-1,540
| Closed | -$209K | – | 132 |
|
|
2020
Q3 | $209K | Hold |
1,540
| – | – | 0.02% | 118 |
|
|
2020
Q2 | $211K | Sell |
1,540
-910
| -37% | -$125K | 0.02% | 101 |
|
|
2020
Q1 | $264K | Hold |
2,450
| – | – | 0.02% | 86 |
|
|
2019
Q4 | $295K | Hold |
2,450
| – | – | 0.02% | 93 |
|
|
2019
Q3 | $244K | Hold |
2,450
| – | – | 0.02% | 84 |
|
|
2019
Q2 | $267K | Hold |
2,450
| – | – | 0.03% | 160 |
|
|
2019
Q1 | $274K | Sell |
2,450
-1,210
| -33% | -$135K | 0.04% | 196 |
|
|
2018
Q4 | $353K | Sell |
3,660
-1,465
| -29% | -$141K | 0.08% | 117 |
|
|
2018
Q3 | $625K | Hold |
5,125
| – | – | 0.08% | 130 |
|
|
2018
Q2 | $563K | Buy |
5,125
+625
| +14% | +$68.7K | 0.07% | 143 |
|
|
2018
Q1 | $480K | Hold |
4,500
| – | – | 0.07% | 144 |
|
|
2017
Q4 | $480K | Buy |
4,500
+3,000
| +200% | +$320K | 0.07% | 139 |
|
|
2017
Q3 | $500K | Hold |
1,500
| – | – | 0.07% | 158 |
|
|
2017
Q2 | $465K | Sell |
1,500
-1,500
| -50% | -$465K | 0.06% | 164 |
|
|
2017
Q1 | $880K | Hold |
3,000
| – | – | 0.13% | 116 |
|
|
2016
Q4 | $796K | Hold |
3,000
| – | – | 0.12% | 113 |
|
|
2016
Q3 | $868K | Hold |
3,000
| – | – | 0.14% | 101 |
|
|
2016
Q2 | $772K | Buy |
+3,000
| New | +$772K | 0.16% | 83 |
|